Author:
Sun Wenguo,Li Haoming,Shi Wenjie,Lv Quanlong,Zhang Weili
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021, 71(3):209–249.
2. Hodson R. Researchers take on the challenge of prostate cancer. Nature. 2022;609(7927):S31.
3. Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, et al. The Proteogenomic Landscape of Curable Prostate Cancer. Cancer Cell. 2019;35(3):414-427.e416.
4. Khoo A, Liu LY, Nyalwidhe JO, Semmes OJ, Vesprini D, Downes MR, Boutros PC, Liu SK, Kislinger T. Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry. Nat Rev Urol. 2021;18(12):707–24.
5. Ding Z, Wang N, Ji N, Chen ZS. Proteomics technologies for cancer liquid biopsies. Mol Cancer. 2022;21(1):53.